MedTrace Logo

CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)

NCT02230241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2016-05-05

No results posted yet for this study

Summary

This is a multi-center survey of patients who are currently receiving lipid-lowering medications and have a moderate or higher cardiovascular (CV) risk. The survey will be conducted in the Russian Federation. Data collection for each study subject will be done within one physician visit. If an enrolled subject comes to the visit not fasting (for at least 8 hours), an appointment for the blood tests will be made for another day.

Conditions

  • Dyslipidaemia

Sponsors & Collaborators

Principal Investigators

  • Alexander Bedenkov · AstraZeneca

  • Sergey Boytsov · State Research Center for Preventive Medicine MoH

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230241 on ClinicalTrials.gov